Valsartan effects on platelet activity in patients with arterial hypertension and metabolic syndrom
То assess angiotensin II receptor blocker effects on platelet aggregation in arterial hypertension (AH) and metabolic syndrome (MS), 34 patients were administered valsartanfor 16 weeks. The dynamics of anthropometry parameters, blood lipids, plasma and platelet lipid peroxidation, blood and blood ce...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2007-06-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/2154 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850026952048508928 |
|---|---|
| author | I. N. Medvedev T. A. Kumova |
| author_facet | I. N. Medvedev T. A. Kumova |
| author_sort | I. N. Medvedev |
| collection | DOAJ |
| description | То assess angiotensin II receptor blocker effects on platelet aggregation in arterial hypertension (AH) and metabolic syndrome (MS), 34 patients were administered valsartanfor 16 weeks. The dynamics of anthropometry parameters, blood lipids, plasma and platelet lipid peroxidation, blood and blood cell antioxidant potential, as well as platelet aggregation was investigated. Statistical analysis included Student and systemic multi-factor analysis methods. In AH and MS patients, valsartan improved peroxidation syndrome and platelet aggregation. For weight reduction, valsartan should be combined with non-pharmaceutical methods. |
| format | Article |
| id | doaj-art-530619bf0e5145ef830ab2bce055315b |
| institution | DOAJ |
| issn | 1560-4071 2618-7620 |
| language | Russian |
| publishDate | 2007-06-01 |
| publisher | «FIRMA «SILICEA» LLC |
| record_format | Article |
| series | Российский кардиологический журнал |
| spelling | doaj-art-530619bf0e5145ef830ab2bce055315b2025-08-20T03:00:22Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202007-06-010366691906Valsartan effects on platelet activity in patients with arterial hypertension and metabolic syndromI. N. Medvedev0T. A. Kumova1Курский институт социального образования – филиал Российского государственного социального университетаКурский институт социального образования – филиал Российского государственного социального университетаТо assess angiotensin II receptor blocker effects on platelet aggregation in arterial hypertension (AH) and metabolic syndrome (MS), 34 patients were administered valsartanfor 16 weeks. The dynamics of anthropometry parameters, blood lipids, plasma and platelet lipid peroxidation, blood and blood cell antioxidant potential, as well as platelet aggregation was investigated. Statistical analysis included Student and systemic multi-factor analysis methods. In AH and MS patients, valsartan improved peroxidation syndrome and platelet aggregation. For weight reduction, valsartan should be combined with non-pharmaceutical methods.https://russjcardiol.elpub.ru/jour/article/view/2154arterial hypertensionmetabolic syndromeplateletsvalsartan |
| spellingShingle | I. N. Medvedev T. A. Kumova Valsartan effects on platelet activity in patients with arterial hypertension and metabolic syndrom Российский кардиологический журнал arterial hypertension metabolic syndrome platelets valsartan |
| title | Valsartan effects on platelet activity in patients with arterial hypertension and metabolic syndrom |
| title_full | Valsartan effects on platelet activity in patients with arterial hypertension and metabolic syndrom |
| title_fullStr | Valsartan effects on platelet activity in patients with arterial hypertension and metabolic syndrom |
| title_full_unstemmed | Valsartan effects on platelet activity in patients with arterial hypertension and metabolic syndrom |
| title_short | Valsartan effects on platelet activity in patients with arterial hypertension and metabolic syndrom |
| title_sort | valsartan effects on platelet activity in patients with arterial hypertension and metabolic syndrom |
| topic | arterial hypertension metabolic syndrome platelets valsartan |
| url | https://russjcardiol.elpub.ru/jour/article/view/2154 |
| work_keys_str_mv | AT inmedvedev valsartaneffectsonplateletactivityinpatientswitharterialhypertensionandmetabolicsyndrom AT takumova valsartaneffectsonplateletactivityinpatientswitharterialhypertensionandmetabolicsyndrom |